you are here: Home News Drug Pricing

Drug Pricing

Trump’s drug pricing overhaul explained: Why his son’s company is under scrutiny
Moneycontrol Selects National Edition: Top stories this morning
Will rise in price caps of essential drugs expose chinks in price control policy?
Commonly used medicines to get 12% more expensive from April
Economic Survey 2023: Govt keeping check on drug prices through direct price control, Janaushadhi stores
NSE-listed ZIM Laboratories eyes nutraceutical segment, regulated markets abroad
Doctors’ body pitches for capping trade margin at 30% for all drugs in India
Doctor-Pharma Nexus Part II: What drives drug prescription in India?
Pharma-Doctor Nexus Part I: Why rules, Code for doctors, drugmakers have failed to curb unethical practices
Regulator fixes retails prices of 45 drugs, many of them drug cocktails
Regulator fixes retail prices of 15 anti-diabetic formulations
Explainer I How the drug price regulator’s order raising the cap on prices of essential medicines by 10.7% may hit you
Retail prices of common medicines set to rise by a steep 11%
Pharma: Trump’s executive orders may possibly provide better market access opportunities
Pharma Weekly: Martin Shkreli goes to jail but his career holds lessons for India
Put price cap on medicines, hip & knee implants: Doctors to PM
Stents pricing: Govt asks hospitals to make prompt refunds
GlaxoSmithKline Pharma Q3 profit dips 33% to Rs 53 cr
No scope of US intervention in Indian pharma cos: Wockhardt
Expect drug pricing pressure to continue in next few years: GSK
Centre's new drug pricing policy comes under SC scanner
NPPA to fix cap on prices of over 300 drugs by month-end
Pharma body challenges government‘s method of pricing
Chemist body seek old margin in new market pricing system
Pharma sector moots market-based pricing: Pfizer

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Drug Pricing

Trump’s drug pricing overhaul explained: Why his son’s company is under scrutiny

Moneycontrol Selects National Edition: Top stories this morning

Will rise in price caps of essential drugs expose chinks in price control policy?

Commonly used medicines to get 12% more expensive from April

Economic Survey 2023: Govt keeping check on drug prices through direct price control, Janaushadhi stores

NSE-listed ZIM Laboratories eyes nutraceutical segment, regulated markets abroad

Doctors’ body pitches for capping trade margin at 30% for all drugs in India

Doctor-Pharma Nexus Part II: What drives drug prescription in India?

Pharma-Doctor Nexus Part I: Why rules, Code for doctors, drugmakers have failed to curb unethical practices

Regulator fixes retails prices of 45 drugs, many of them drug cocktails

Regulator fixes retail prices of 15 anti-diabetic formulations

Explainer I How the drug price regulator’s order raising the cap on prices of essential medicines by 10.7% may hit you

Retail prices of common medicines set to rise by a steep 11%

Pharma: Trump’s executive orders may possibly provide better market access opportunities

Pharma Weekly: Martin Shkreli goes to jail but his career holds lessons for India

Put price cap on medicines, hip & knee implants: Doctors to PM

Stents pricing: Govt asks hospitals to make prompt refunds

GlaxoSmithKline Pharma Q3 profit dips 33% to Rs 53 cr

No scope of US intervention in Indian pharma cos: Wockhardt

Expect drug pricing pressure to continue in next few years: GSK

Centre's new drug pricing policy comes under SC scanner

NPPA to fix cap on prices of over 300 drugs by month-end

Pharma body challenges government‘s method of pricing

Chemist body seek old margin in new market pricing system

Pharma sector moots market-based pricing: Pfizer